William Staggers
Plastic Surgery · Fairhope, ALNPI 1952393951
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $120,061 of the $182,983 with a category attached, or 65.6%. Organogenesis Inc. accounts for 99.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $50,685 and has fallen 86.2% since, to $7,009 in 2025. Among plastic surgery clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 411 payments — averaging $445.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$183K
- Surmodics, Inc.$42
- Orexo US, Inc.$24
- Bsn Medical Inc$21
- Smith+Nephew$20
What the payments were for
- Consulting fees$35,00019%
- Speaking & faculty fees$120,06166%
- Travel & lodging$23,11713%
- Food & beverage$4,8053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 405 | $182,876 |
| Surmodics, Inc. | 2 | $42 |
| Orexo US, Inc. | 2 | $24 |
| Bsn Medical Inc | 1 | $21 |
| Smith+Nephew | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$74,102
- Puraply Antimicrobial$51,511
- Apligraf$26,082
- Dermagraft$23,972
- Puraply/Affinity/NuTech$23,972
- PURAPLY WOUND MATRIX$16,368
- Affinity$12,261
- NOVACHOR$2,110
- NuShield$2,110
How this compares
$182,983 in reported general payments places this provider in the 95th percentile of 35 plastic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 786 | $200,926 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 111 | $75,396 |
| MounjaroTirzepatide | 13 | $13,007 |
| Varenicline Tartrate | 46 | $10,204 |
| Gabapentin | 276 | $2,841 |
| Ondansetron OdtOndansetron | 87 | $1,386 |
| Clonazepam | 136 | $1,103 |
| Gentamicin Sulfate | 29 | $1,051 |
| Hydroxyzine Pamoate | 76 | $1,045 |
| Naloxone Hcl | 15 | $1,001 |
| Trazodone Hcl | 64 | $983 |
| Ondansetron Hcl | 88 | $936 |
| Mirtazapine | 75 | $865 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $829 |
| Pregabalin | 44 | $618 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Fairhope
- Ryan ReboweMobile$24K
- Analise ThomasVestavia$20K
- Stephen SteinmetzBirmingham$18K
- Alvin CohnVestavia$15K
- Christopher SchafferBirmingham$12K
- Melanie PetroVestavia$10K
- James GunnBirmingham$9K
- Christopher ParkMobile$7K
- Ross BunchTuscaloosa$6K
- Michael ClintonBirmingham$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.